NGNE - Neurogene Inc.
14.73
-0.270 -1.833%
Share volume: 173,021
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$15.00
-0.27
-0.02%
Summary score
42%
Profitability
35%
Dept financing
30%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-11.46%
Return on sales
-2176.65%
Return on invested capital
0%
Total debt ratio
31.99%
Debt ratio change over timeo
0%
Current Ratio
14.64%
Quick Ratio
0%
Cash Position Ratio
8.09%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-9.95%
Return on sales
-2176.65%
Return on invested capital
0%
Total debt ratio
11.27%
Debt ratio change over timeo
0%
Current Ratio
15.78%
Quick Ratio
0%
Cash Position Ratio
6.69%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-8.25%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
7.46%
Debt ratio change over time
0%
Current Ratio
21.03%
Quick Ratio
0%
Cash Position Ratio
5.02%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NGNE | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 14.28% | 9.23% | 0% |
| Return on assets | -11.46% | 4.23% | 3.2% | 0% |
| Return on sales | -2176.65% | 27.89% | 25.03% | 0% |
| Return on invested capital | 0% | 8.36% | 9.37% | 0% |
| Profitability | 0% | 97% | 83% | 0% |
| Total debt ratio | 31.99% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | 0% | -11.36% | -57.43% | 0% |
| Dept financing | 35% | 25% | 18% | 0% |
| Current Ratio | 15.78% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 6.69% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 26% | 29% | 0% |
| Short-term ratios | NGNE | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -9.95% | 4.32% | 3.49% | 0% |
| Return on sales | -2176.65% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 0% |
| Total debt ratio | 11.27% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 25% | 18% | 0% |
| Current Ratio | 15.78% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 6.69% | 0.12% | 0.5% | 0% |
| Liquididy | 50% | 27% | 27% | 0% |
